BioSpace News Archive

Drug Development

Liquidia Initiates Phase III Clinical Trial of LIQ861 in Patients with Pulmonary Arterial Hypertension

Liquidia announced the initiation of a Phase 3 clinical trial evaluating LIQ861 for the treatment of pulmonary arterial hypertension (PAH).

January 3, 2018
·
4 min read
Business

Simulations Plus Sets Date for 1st Quarter 2018 Earnings Release and Conference Call

The Company will host a conference call on January 9, 2018, at 4:15 p.m. Eastern Time.

January 3, 2018
·
1 min read
Business

Indiana Biosciences Research Institute Names Lilly Executive Jay McGill COO

McGill brings vast experience in collaboration, partnership, research operations and ventures to the IBRI.

January 3, 2018
·
3 min read
Web Biotech Announces Pre-Series A Convertible Loan Funding From SGinnovate

Web Biotech today announced a Pre-series A financing round from SGinnovate.

January 3, 2018
·
2 min read
Deals

Generex Announces Initial Pharmacy Acquisitions & Plans for Broader Acquisitions Strategy

Generex Biotechnology Corporation today announced that it has completed the acquisition of two pre-operational retail pharmacy operations.

January 3, 2018
·
3 min read
Deals

China Biologic Announces Completion of Acquisition of TianXinFu From PWM

China Biologic Products today announced that it has completed the acquisition of 80% equity interest in Tianxinfu from PW Medtech Group Limited.

January 3, 2018
·
2 min read
H2-Pharma and CHEPLAPHARM Announce Re-Launch of XENICAL Capsules

H2-Pharma announced today that it has re-launched XENICAL (orlistat) 120 mg Capsules via its newly formed Branded division.

January 3, 2018
·
1 min read
BioMidwest

Spectrum Brands’ Rayovac Introduces New PRO LINE® Advanced

Rayovac’s new PRO LINE Advanced combines long lasting power with an easy to use package.

January 3, 2018
·
5 min read
Business

Agenus Announces Key Leadership to Advance Combination Trials For Planned BLA Filings

Agenus announced new leadership appointments to enhance its team and advance combination clinical programs which will support its planned BLA filings in the second half of 2019 and in 2020.

January 3, 2018
·
5 min read
Business

Foresee and Megapharm Announce License and Distribution Agreement

Foresee and Megapharm announced today that they have entered into an exclusive license and distribution agreement for the commercialisation in Israel and the Palestinian Authority of Foresee’s FP-001 program.

January 3, 2018
·
3 min read